$24.8M
Qualified
maximum offering price, as qualified
—
Reported Sold
no 1-K or 1-Z states a sold amount
10
Filings
across 1 offering
Equity Classes
| Type | Class | Outstanding | CUSIP |
|---|---|---|---|
| common | N/A | 4,196,192 | US03753V1 |
Service Providers
| Role | Provider | CRD |
|---|---|---|
| auditor | Marcum LLP | — |
| legal | Morgan Lewis & Bockius LLP | — |
| underwriter | WR Hambrecht & Co LLC | 45040 |
Offerings
| File Number | Filings | First Filed | Last Filed | Price/Security | Securities Offered | Outstanding | Aggregate Offering | Withdrawn | CRD |
|---|---|---|---|---|---|---|---|---|---|
| 024-10482 | 10 | 2015-09-21 | 2016-01-19 | $8.00 | 3,100,000 | 4,196,192 | $24.8M | 2016-11-21 | 45040 |
The statements and reported figures behind Aperion Biologics, Inc.
Operations, the balance sheet and cash flows as filed, year by year — the filer's own captions, not a mapped chart of accounts — plus the tagged figures from every Form 1-A family filing, plotted on the dates they were actually reported. EDGAR still has each 1-K; the dashboard lays every year they filed next to it.
- Every caption as the filer wrote it, across every annual report — not just the latest 1-K
- Tagged reported figures across every filing — revenue, assets, cash — with a sparkline on the actual filing dates
- A sparkline on each annual-statement line, so the shape is visible before the figures
- A revenue series dated to the filings that reported it
- A filing history that says what each document contributed, not only that it exists
- Follow it, and see it change on your watchlist
External link: SEC Filings